# US 2012/0252122 A1 · Methods and compositions for increasing production of induced pluripotent stem cells (ipscs)

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252122 A1
- Document ID: US20120252122A1
- Status: Published application
- Kind: A1
- Application number: 13/326,882
- Filed: 2011-12-15
- Published: 2012-10-04
- Earliest claimed: 2011-01-05
- Assignees: Sangamo BioSciences, Inc.
- Inventors: Josee LAGANIERE
- Web page: https://patentgrep.com/patent/US20120252122A1

## CPC

- C12N 5/0696: {Artificially induced pluripotent stem cells, e.g. iPS}
- A01K 2227/40: Fish
- C12N 2506/1307: from adult fibroblasts
- C12N 2523/00: Culture process characterised by temperature
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A01K: ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS

## Abstract

Disclosed herein are methods and compositions for increasing yield of induced pluripotent stem cells (iPSCs).

## Claims

### Claim 1

A method of producing induced pluripotent stem cells (iPSCs) from differentiated somatic cells, the method comprising
(a) subjecting the differentiated somatic cells to cold shock conditions; and
(b) culturing the differentiated somatic cold-shocked cells under conditions such that iPSCs are produced.

### Claim 2 (depends on 1)

The method of claim 1, wherein the differentiated somatic cells are selected from the group consisting of fibroblasts, keratinocytes, peripheral blood cells and astrocytes.

### Claim 3 (depends on 1)

The method of claim 1, where the differentiated somatic cells are genetically modified.

### Claim 4 (depends on 3)

The method of claim 3, wherein the genetic modification is mediated by a nuclease and further wherein the nuclease is introduced into the differentiated somatic cells prior to the cold shock conditions.

### Claim 5 (depends on 3)

The method of claim 3, wherein the genetic modification is mediated by a nuclease and further wherein the nuclease is introduced into the differentiated somatic cells during cold shock conditions.

### Claim 6 (depends on 5)

The method of claim 5, further comprising providing an exogenous sequence to the cells under conditions such that the nuclease mediates targeted integration of the exogenous sequence into the genome of the cells, thereby genetically modifying the differentiated somatic cells.

### Claim 7 (depends on 6)

The method of claim 6, wherein the exogenous sequence comprises a reporter gene.

### Claim 8 (depends on 7)

The method of claim 7, further comprising the step of isolating the cells expressing the reporter gene.

### Claim 9 (depends on 4)

The method of claim 4, wherein the modification comprises a deletion.

### Claim 10

A kit for increasing the yield of iPSCs, the kit comprising,
one or more nucleases and
instructions for introducing the nucleases into differentiated somatic cells and cold shocking the cells to increase yield of iPSCs.
